Submission Information

ABSTRACT SUBMISSIONS OPEN NOW
Gain unparalleled exposure for your research and network with global key opinion leaders and decision-makers including C-suite, directors, and managers of leading organizations and labs in the cell and gene therapy space.

Submit Now

THREE WAYS TO SHOWCASE YOUR WORK!

POSTER HALL

ISCT 2025 New Orleans will feature a large Poster Hall open to delegates throughout the meeting.

In addition, ISCT will host two dedicated poster networking receptions during which all meeting delegates gather in the Poster Hall to review research, discuss findings and network with presenters.

ORAL PRESENTATIONS

48 high-scoring abstracts will be invited to give a 10-minute presentation of their work at one of the 8 oral abstract sessions. 

Oral abstract sessions are well-attended attracting over 200 delegates.

ELEVATOR PITCH

Thirty high-scoring abstracts will be invited to present their abstract as an elevator pitch and compete for the Best Elevator Pitch Award.

Presenters will have 2 minutes to summarize their research and its impact on the field.

WHY PRESENT AT ISCT?

A Truly Translational Focus on a Global Platform
Whether you focus on basic science and preclinical studies, clinical investigations, manufacturing, regulatory, quality, policy, ethics, or commercialization, your work is vital to advancing the field of cell and gene therapy. ISCT is the place for you to discuss your research with a global community of experts across the translation field.    

Showcase Your Research  - Get Feedback, Collaborate
Be considered for an oral abstract, elevator pitch presentation, or poster presentation and promote your work to global leaders in the cell and gene therapy sector.  Gain exposure to key opinion leaders, potential collaborators, future employers, and expand your professional network.   

Publish Your Work
Accepted abstracts will be published in a special supplement of Cytotherapy, the official journal of ISCT, providing an excellent opportunity to showcase your work to a global translational audience. Many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.

Qualify for Awards
ISCT recognizes outstanding abstracts and presentations. At ISCT 2024 Vancouver, 31 winners were awarded a combined total of over $30,000. Submit an abstract and join ISCT 2025 New Orleans to qualify!

Launch Your Career
ISCT is invested in the future of our sector and has created exclusive opportunities for Early Stage Professionals to present their work at ISCT 2025. Students, recent grads, and postdocs are encouraged to submit.

More information coming soon.

CONFIRMED AWARDS

  • Top Scoring Abstract Award
  • Best Poster Award
  • Best Elevator Pitch Abstract Award
  • Early Stage Professionals Award
  • Technologist Award

More awards will be announced in upcoming weeks.

Eligibility Criteria: Individuals must be presenting an abstract at ISCT 2025 and hold a current ISCT membership.

Submit Now

KEY DATES


ABSTRACT SUBMISSION CLOSES
January 10, 2025

NOTIFICATION OF ACCEPTANCE
February 7, 2025

ACCEPTED ABSTRACT RSVP AND REGISTRATION DEADLINE
February 24, 2025

ABSTRACT CATEGORIES

  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapies (AAVs, LNPs, nucleotide-based therapies)
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access

GUIDELINES AND POLICIES

  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables.

  • Note that spaces count as characters.

  • Ensure that any references to licensed products are labelled with their non-proprietary names.

  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.

  • There are limited opportunities for oral talks. Invitations to give an oral presentation are based on the quality and scope of the submitted abstract as determined through our blinded-review process.

  • The inclusion of all relevant data to your topic is strongly encouraged as Reviewers will evaluate this when scoring submitted abstracts.

  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than February 24th, 2025. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.

  • Abstract presenters MUST be registered for the meeting.

  • All accepted abstracts are subject to the ISCT Embargo Policy until April 30, 2025.
  • Abstracts submitted to the ISCT 2025 Annual Meeting are embargoed from the time of submission until April 30th, 2025.

  • For the abstract to be eligible for presentation at the ISCT 2025 Annual Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2025 Annual Meeting.

  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT 2025 Annual Meeting. Publication before the meeting may result in the abstract being removed from the conference.

  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT from presentation at the ISCT 2025 Annual Meeting and from publication in the abstract supplement.

*An embargo means that information from any abstract or presentation may not be
announced, publicized, or distributed before the embargo date and time.

ISCT generally does not accept encore abstracts unless there are substantial data updates. However, exceptions may be granted upon written request to jan@isctglobal.org, provided your request includes a clear justification for the encore abstract (e.g. if the ISCT audience significantly differs from the initial presentation).

* An encore abstract is the resubmission of an original abstract
that has previously been presented at another conference